A8MV72
Putative UPF0607 protein ENSP00000382826
Also known as: YH009_HUMAN
Protein identityUniProt · HPA
OverviewNCBI Gene
No narrative summary is available for A8MV72 in this catalog release; identity and structured annotations are shown without generated factual claims.
Canonical amino-acid sequenceUniProt
311 residues, UniProt reviewed canonical sequence.
>A8MV72|A8MV72
1 MLSARNSMMF GHLSPVRIPR LRGKFNLQLP SLDEQVIPAR LLKMEVRAEE PKEATEVKDQ
61 VETQGQEDNK MGPCSNGEAA STSRPLETQG NLTSSWYNPR PLEGNVHLKS LTEKNQTDKA
121 QVHAVSFYSK GHGVASSHSP AGGILPFGKP DPLPTVLPAP VPGCSLWPEK AALKVLGKDH
181 LPSSPGLLMV GEDMQPKDPA VLGSSRSSPP RAAGHRSRKR KLSGPPLQLQ LTPPLQLRWD
241 RDGGPPPAKL PCLSPEALLV GQASQREGRL QQGNMRKNMR VLSRTSKFRR RKQLLRRRKK
301 TRQGRRGGSC LLocalizationUniProt · AlphaFold · HPA
Whether an antibody against A8MV72 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.72
Protein domainsUniProt · Pfam · InterPro
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads A8MV72 as an antibody target. Whether an autoantibody or antibody against A8MV72 could matter depends on whether native A8MV72 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
A8MV72 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label A8MV72 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...